Published on UCD National Virus Reference Laboratory (https://nvrl.ucd.ie)

Home > NS5A resistance leading to failure of 24-week therapy with sofosbuvir/ledipasvir and ribavirin for the treatment of hepatitis C genotype 1a infection in a HIV-1 co-infected patient
posted by Anonymous on 23 June 2016

NS5A resistance leading to failure of 24-week therapy with sofosbuvir/ledipasvir and ribavirin for the treatment of hepatitis C genotype 1a infection in a HIV-1 co-infected patient

Sevastianova K, Dean J, Bannan C, Coghlan M, Farrell G, Murray C, De Gascun CF, Bergin C
J Clin Virol. 2016 Sep;82:66-69

10.1016/j.jcv.2016.06.012

UCD National Virus Reference Laboratory, University College Dublin, Belfield, Dublin 4, D04 E1W1, Ireland    Tel: +353 1 7164401, Email: nvrl@ucd.ie

UCD Homepage | Gaeilge | Privacy | Disclaimer | Freedom of Information | Acceptable Use Policy

Source URL:https://nvrl.ucd.ie/node/175